Related Experiment Videos

Phase II study of high-dose medroxyprogesterone acetate in advanced malignant melanoma

R Becher¹, O Kloke, K Höffken

¹Innere Klinik und Poliklinik (Tumorforschung), Westdeutsches Tumorzentrum, Essen, Federal Republic of Germany.

British Journal of Cancer

|June 1, 1989

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Low-dose ipilimumab plus nivolumab combined with IL-2 and hyperthermia in cancer patients with advanced disease: exploratory findings of a case series of 131 stage IV cancers - a retrospective study of a single institution.

Cancer immunology, immunotherapy : CII·2020

Thymosin beta 15A (TMSB15A) is a predictor of chemotherapy response in triple-negative breast cancer.

British journal of cancer·2012

Long-term outcome after neoadjuvant radiochemotherapy in locally advanced noninflammatory breast cancer and predictive factors for a pathologic complete remission : results of a multivariate analysis.

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]·2012

Do insulin-like growth factor associated proteins qualify as a tumor marker? Results of a prospective study in 163 cancer patients.

European journal of medical research·2011

Gene Therapy for Treatment of Brain Tumors (HSV-tKIn Vivo Gene Transfer) : A Case Study.

Methods in molecular medicine·2011

Methylated APC and GSTP1 genes in serum DNA correlate with the presence of circulating blood tumor cells and are associated with a more aggressive and advanced breast cancer disease.

European journal of medical research·2010

See all related articles